Patrick Brossard

Title: The Innovations of Patrick Brossard

Introduction

Patrick Brossard is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosing regimens for selective S1P receptor agonists. With a total of three patents to his name, Brossard's work is paving the way for advancements in heart treatment.

Latest Patents

One of Patrick Brossard's latest patents focuses on a dosing regimen for a selective S1P receptor agonist. This invention details a method of administering the agonist to a subject in a way that induces desensitization of the heart during the initial treatment phase. The dosing is carefully calibrated to be below the target dose, with a frequency that maintains heart desensitization until no further acute heart rate reduction occurs. Following this phase, the regimen allows for dose up-titration to reach the target dose of the selective S1P receptor agonist.

Career Highlights

Brossard is currently employed at Actelion Pharmaceuticals Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on improving patient outcomes through targeted therapies.

Collaborations

Throughout his career, Patrick Brossard has collaborated with esteemed colleagues such as Jasper Dingemanse and Oliver Nayler. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.

Conclusion

Patrick Brossard's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his commitment to improving heart treatment methodologies. His work at Actelion Pharmaceuticals Ltd. and collaborations with other professionals further underscore his impact in the industry.